Orion Infusions (DHA:ORIONINFU) Interest Expense : BDT-30.5 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Orion Infusions's interest expense for the three months ended in Dec. 2023 was BDT -8.6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was BDT-30.5 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Orion Infusions's Operating Income for the three months ended in Dec. 2023 was BDT 19.5 Mil. Orion Infusions's Interest Expense for the three months ended in Dec. 2023 was BDT -8.6 Mil. Orion Infusions's Interest Coverage for the quarter that ended in Dec. 2023 was 2.27. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orion Infusions Interest Expense Historical Data

The historical data trend for Orion Infusions's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Interest Expense Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

-30.15

-39.25

-28.82

-29.45

-29.51

Orion Infusions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-7.59	-6.38	-7.95	-7.59	-8.61

Orion Infusions Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-30.5 Mil.

Orion Infusions (DHA:ORIONINFU) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Orion Infusions's Interest Expense for the three months ended in Dec. 2023 was BDT-8.6 Mil. Its Operating Income for the three months ended in Dec. 2023 was BDT19.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was BDT9.0 Mil.

Orion Infusions's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	19.538	/	-8.614
	=	2.27

The higher the ratio, the stronger the company's financial strength is.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines